Real-life effectiveness evaluation of the long-acting muscarinic antagonist aclidinium bromide (Eklira®) for the management of COPD in a routine UK primary care population - Study 1 (Real-life acceptability of Eklira) First published 19/05/2014 Last updated 17/03/2015 EU PAS number:EUPAS6573 Study Finalised